Work to Make a Difference – Michael Ullmann

SpreadLove In Organizations
SpreadLove In Organizations
Work to Make a Difference - Michael Ullmann
/

Being in healthcare is a privilege and a humbling responsibility; we impact lives. This is what Michael Ullman has done throughout his years at Johnson & Johnson from where he retired recently as Executive VP, General Counsel & Executive Committee Member. Leadership for Mike is grounded in humility, kindness, and optimism, it is above all a responsibility to other people. Hear Mike’s experience leading JNJ to deliver on covid vaccine that saved humanity during the pandemic, and his thoughts on ESG, Health Equity, social responsibility, and how to build high-performing teams to ensure we deliver on our purpose. As leaders, our job is not to be superstars but rather shine through others, through our people’s greatness. Kindness is underused in the world, create a culture that demands it, treat people with respect, trust them, empower them, and help them succeed.

“Kindness is underused. Create a culture that demands it.”

MEET OUR GUEST Michael Ullmann, (Retired) Executive Vice President, General Counsel & Executive Committee Member, Johnson & Johnson

Michael Ullmann retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and Security. 

As General Counsel of the world’s largest Life Sciences company, he successfully guided JNJ through high-profile and high-risk situations, while helping to grow the business to annual sales of $94 billion, increase shareholder value and maintain its reputation as one of the most admired companies in the world. 

Mike joined Johnson & Johnson in 1989 as a mergers & acquisitions attorney and held various management positions, including General Counsel of the Worldwide Medical Devices Group, before becoming the company’s General Counsel in 2012. Michael is a member of the Board of Directors of Americares and serves on the Columbia Law School Board of Visitors. 

EPISODE TRANSCRIPT: Michael Ullmann

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host, joined today by Mike Ullmann. Mike retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and…

Lead From the Heart – Jean Jacques Bienaime

SpreadLove In Organizations
SpreadLove In Organizations
Lead From the Heart - Jean Jacques Bienaime
/

This episode is special and the first in a series of three. In partnership with ESCP Business School, I’ll be giving the mic to students, the leaders of tomorrow, to discuss with seasoned healthcare executives about their journeys and leadership beliefs. We welcomed in this first episode, Jean Jacques Bienaimé, CEO of BioMarin who shared his story, experience, and words of wisdom. “Love is an infinite resource that will have a tremendous impact on people”, this summarizes beautifully JJ’s leadership beliefs that helped him build high-performing teams delivering successful innovations to patients across the world.

“Employees are the oxygen of any company; its most important component.”

MEET OUR GUEST Jean Jacques Bienaime (JJ), CEO and member of the BOD of BioMarin.

Jean-Jacques Bienaime joined BioMarin in 2005 as Chief Executive Officer and member of the board of directors, bringing with him over 25 years of experience in the biotechnology and pharmaceutical industries. Under his leadership, the market capitalization of BioMarin went from around $450 million in 2005 to approximately $14 billion in 2021. Before being the CEO of BioMarin, Jean-Jacques held several senior management positions in the biotech industry including CEO and chairman of Sangstat Medical Corporation and Genencor.

Mr. Bienaimé currently serves on the boards of Incyte Corporation, a biotechnology company, PhRMA, and The Biotech Industry Organization. He received an M.B.A. from the Wharton School at the University of Pennsylvania and a degree in economics from the École Supérieure de Commerce de Paris (ESCP Business School).